LAPORAN TAHUNAN 2014 - idx.co.id .farmasi, suplemen makanan dan alat kesehatan dengan cakupan seluruh

  • View
    218

  • Download
    0

Embed Size (px)

Text of LAPORAN TAHUNAN 2014 - idx.co.id .farmasi, suplemen makanan dan alat kesehatan dengan cakupan...

  • PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

    LA PO

    R A

    N TA

    H U

    N A

    N 2

    0 1

    4 A

    N N

    U A

    L R EPO

    RT PT M ILLEN

    N IU

    M PH

    A R

    M A

    C O

    N IN

    TER N

    A TIO

    N A

    L Tb k

    Gedung Bank Panin Pusat, Lantai 9 Jl. Jendral Sudirman, Senayan Jakarta 10270 - INDONESIA Telp. (62-21) 7278-8906, 7278-8907 Fax. (62-21) 722-8090, 720-5835 Website: http://www.mpi-indonesia.co.id

  • ULASAN SAMPUL COVER DESCRIPTION

    Habbatussauda

    Habbatussauda banyak dikenal dengan berbagai nama, diantaranya black seed, black caraway, natura seed, jintan hitam, black cumin, nigella sativa, kaluduru, dan lain-lain. Digunakan sebagai herbal pengobatan sejak 2000-3000 tahun sebelum Masehi dan tercatat dalam banyak literatur kuno mengenai ahli pengobatan terdahulu seperti Ibnu Sina (980 - 1037 M), dan Al-Biruni (973-1048 M), Al-Antiki, Ibnu Qayyim dan Al-Baghdadi. Ibnu Sina adalah peneliti jenius dari Timur Tengah di bidang pengobatan yang namanya tercatat di semua buku sejarah pengobatan timur maupun barat, hidup antara 980 – 1037 M, telah meneliti berbagai manfaat Habbatussauda untuk kesehatan dan pengobatan. Ahli pengobatan Yunani kuno, Dioscoredes, pada abad pertama Masehi juga telah mencatat manfaat habbatussauda untuk mengobati sakit kepala dan saluran pernapasan.

    MPI saat ini mendistribusikan produk Habbatussauda dengan label nama Baraka.

    Habatussauda wildly known by various name, as black seed, black caraway, natura seed, jintan hitam, black cumin, nigella satuva, kaluduru, and others. Used in herbal medicine since 2000 – 3000 BC and recorded in many ancients literature regarding previous treatment expert such as Ibnu Sina (980 – 1037 AD) and Al-Biruni (973-1048 AD), Al-Antiki, Ibnu Qayyim and Al-baghdadi. Ibn Sina was a genius researcher in Middle East in the field of medicine, his named is recorded in all history medicine books eastern and western, lived in 980 -1037 AD and has been reserching

    .enicidem dna htlaeh rof deeS kcalB fo tifeneb eht Ancient Greek medicine expert, Dioscoredes in the first century AD have also noted the benefits of Black Seed/Habatussauda to treat headaches and respiratory tract.

    Currently MPI is distributing Habbatussauda under brand name Baraka.

  • 1

    PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

    DAFTAR ISI TABLE OF CONTENTS

    Ulasan Sampul Cover Description

    Bidang dan Kegiatan Usaha Perusahaan2. Business Activities of the Company

    Visi dan Misi Perusahaan2. Vision and Mission of the Company

    Ikhtisar Data Keuangan Penting3. Important Financial Highlights

    Informasi Harga Saham 2 Tahun Terakhir4. Share Price Information For the Last 2 Years

    Laporan Dewan Komisaris6. Report of the Board of Commissioners

    Laporan Direksi Report of the Board of Directors

    Profil Perusahaan Company Profile

    Analisis dan Pembahasan Manajemen Management Analysis and Discussion

    Tata Kelola Perusahaan Good Corporate Governance

    Laporan Tanggung Jawab Sosial Perusahaan Corporate Social Responsibility (CSR)

    Informasi Tambahan Additional Information

    Laporan Keuangan

    Pernyataan Dewan Komisaris dan Direksi atas Laporan Tahunan Statement of the Board of Commissioners and the Board of Directors on the Annual Report

    Alamat yang dapat dihubungi Pemegang Saham dan Masyarakat untuk Memperoleh Informasi mengenai Perusahaan Contact address for Shareholders and Public to find any information of the Compnay

    Financial Statements

    Prinsipal-Prinsipal

    Jaringan Distribusi

    Pernyataan Tanggung Jawab Direksi atas Laporan Keuangan

    10.

    14.

    34.

    39.

    43.

    44.

    47.

    47.

    48.

    49.

    45.

    46.

    Principals

    Distribution Network

    Statement of the Board of Directors’ Responsibility on the Financial Statements

  • 2

    PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

    VISI DAN MISI PERUSAHAAN

    VISI

    MISI

    BIDANG DAN KEGIATAN USAHA PERUSAHAAN

    VISION AND MISSION OF THE COMPANY

    VISION

    MISSION

    BUSINESS ACTIVITIES OF THE COMPANY

    PT Millennium Pharmacon International Tbk is engaged in the distribution of pharmaceutical products, food supplement and medical devices with nationwide coverage. It operates with 30 branch offices, 3 sub distributors, 3 pooling warehouses and 65 sales stations.

    The Company’s principals comprises of local as well as international companies. Ethical products and medical devices are distributed to various outlets such as pharmacies, hospitals and drugstores, meanwhile the Over The Counter (OTC) products are distributed via supermarkets and hypermarkets.

    To be the most efficient and effective distribution company in Indonesia bringing added value to both our customers and principals.

    To provide excellent healthcare products and services nationwide.

    PT Millennium Pharmacon International Tbk bergerak di bidang distribusi produk farmasi, suplemen makanan dan alat kesehatan dengan cakupan seluruh Indonesia (nationwide) beroperasi dengan 30 kantor cabang, 3 sub distributor, 3 gudang pool dan 65 station penjualan.

    Prinsipal yang mempercayakan produknya didistribusikan terdiri dari prinsipal nasional maupun prinsipal multi nasional dengan sasaran distribusi apotik, rumah sakit untuk produk-produk ethical dan alat kesehatan dan toko obat maupun pasar modern untuk produk-produk bebas (Over The Counter).

    Menjadi perusahaan distribusi yang paling efisien dan efektif di Indonesia dengan memberikan nilai tambah kepada para pelanggan dan prinsipal.

    Menyediakan produk pemeliharaan kesehatan dan pelayanan yang terbaik ke seluruh wilayah nusantara.

  • 3

    PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

    IKHTISAR DATA KEUANGAN PENTING IMPORTANT FINANCIAL HIGHLIGHTS

    201420132012

    UNTUK TAHUN YANG BERAKHIR PADA 31 DESEMBER FOR THE YEAR ENDED DECEMBER 31ST

    KONDISI KEUANGAN/ FINANCIAL CONDITION

    Total Aset/ Total Assets

    Piutang Usaha/ Trade Receivable

    Persediaan/ Inventory

    Aset Tetap - Bersih/ Fixed Assets - Net Book Value

    Aset takberwujud - Bersih/ Intangible Assets - Net Book Value

    Total Aset Lancar/ Total Current Assets

    Total Aset Tidak Lancar/ Total Non Current Assets

    Total Liabilitas/ Total Liabilities

    Total Liabilitas Jangka Pendek/ Total Current Liabilities

    Total Liabilitas Jangka Panjang/ Total Non Current Liabilities

    Modal Kerja - Bersih/ Net Working Capital

    Ekuitas - Bersih/ Equity

    OPERASIONAL/ OPERATIONAL

    Penjualan Bersih/ Total Net Sales

    Laba Bruto/ Gross Profit

    Laba Usaha/ Operating Profit

    Laba (Rugi) Bersih/ Net Income (Loss)

    Laba (Rugi) Komprehensif/ Comprehensive Income (Loss)

    Jumlah saham yang beredar/ Number Of Shares

    Laba (Rugi) per Saham/ Net Income (Loss) per Share

    RASIO KEUANGAN/ FINANCIAL RATIO

    Likuiditas/ Liquidity

    Current Ratio/ Current Ratio

    Acid Test Ratio/ Acid Test Ratio

    Aktivitas/ Activity

    Perputaran Piutang/ Receivable Turnover

    Perputaran Persediaan/ Inventory Turnover

    Perputaran Aset Tetap/ Fixed Asset Turnover

    Perputaran Total Aset/ Total Asset Turnover

    Solvabilitas/ Solvability

    Rasio Liabilitas Jangka Panjang terhadap Ekuitas/ Long Term Debt to

    Rasio Liabilitas terhadap Ekuitas/ Debt to Equity Ratio

    Rasio Liabilitas terhadap Total Aset/ Debt to Assets Ratio

    Profitabilitas/ Profitability

    Rasio Laba (Rugi) Bersih terhadap Total Aset/ Return on Investment

    Rasio Laba (Rugi) Bersih terhadap Ekuitas/ Return on Equity

    Rasio Laba (Rugi) Bersih terhadap Penjualan Bersih/ Return on Sales

    385.610

    176.008

    140.021

    7.242

    8.034

    364.968

    20.642

    280.985

    266.856

    14.128

    98.112

    104.625

    1.172.975

    104.459

    22.937

    9.848

    -

    728

    14

    136.77%

    84.30%

    6.66

    7.63

    161.96

    3.04

    13.50%

    268.56%

    72.87%

    2.55%

    9.41%

    0.84%

    471.677

    206.788

    191.382

    8.292

    6.194

    451.139

    20.539

    356.805

    340.303

    16.503

    110.836

    114.872

    1.310.244

    120.462

    28.912

    10.247

    -

    728

    14

    132.57%

    76.33%

    6.34

    6.22

    158.01

    2.78

    14.37%

    310.61%

    75.65%

    2.17%

    8.92%

    0.78%

    529.992

    216.865

    193.058

    11.144

    4.353

    504.808

    25.183

    408.203

    387.958

    20.245

    116.851

    121.789

    1.437.668

    131.534

    31.852

    7.319

    6.917

    728

    10

    130.12%

    80.36%

    6.63

    6.77

    129.01

    2.71

    16.62%

    335.17%

    77.02%

    1.38%

    6.01%

    0.51%

    (dalam jutaan rupiah kecuali laba (rugi) per saham dan rasio-rasio) (in millions rupiah except for earnings (loss) per share and ratios)